← Eichor
Study identifier: NCT06386354 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Residual Neuromuscular Block in the Post-Anesthetic Unit and Postoperative Complications

Condition: Postoperative Neuromuscular Block · Postoperative Complications  ·  Sponsor: Hospital Universitario de Gran Canaria Doctor Negrín

PhaseN/A
Planned participants296
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The use of neuromuscular blockers (NMB) is essential to optimize surgical conditions, ensure patient immobility during the intervention and prevent complications derived from involuntary movements. Intraoperative monitoring of neuromuscular relaxation allows the depth of neuromuscular blockade to be accurately evaluated, guaranteeing ideal conditions for the surgical team. Residual neuromuscular blockade (RNMB) is the persistence of muscle paralysis after the administration of NMB during a surgical intervention. The appearance of RNMB poses substantial challenges in the postoperative period, as it has negative repercussions for the safety and well-being of the patient.

This description comes directly from the study's public registry record.

Talk to the study team

Ángel Becerra Bolaños, PhD  ·  +34928450370  ·  angbecbol@gmail.com

Aurelio Rodríguez Pérez, PhD  ·  +34928450370  ·  arodperp@gobiernodecanarias.org

Always discuss trial participation with your own doctor first.

Locations (2)

Hospital Universitario de Gran Canaria Doctor NegrínLas Palmas de Gran Canaria, Las Palmas, SpainRecruiting
Ángel BecerraLas Palmas de Gran Canaria, Las Palmas, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06386354